We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Postmarketing commitment studies are becoming increasingly important in the drug approval process in the U.S., and the FDA is requesting them more often, according to a recent study.